Susquehanna Fundamental Investments, LLC Anavex Life Sciences Corp. Call Options Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AVXL
# of Institutions
177Shares Held
28.5MCall Options Held
583KPut Options Held
705K-
Black Rock Inc. New York, NY6.39MShares$54.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$39.6 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$20.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$15.9 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.13MShares$9.61 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $660M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...